Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.100409 USD
56.52 M USD
918.60 M USD
114.66 M
About Hangzhou Tigermed Consulting Co., Ltd. Class A
Sector
Industry
CEO
Xiao Chun Cao
Website
Headquarters
Hangzhou
Founded
2004
IPO date
Aug 17, 2012
Identifiers
2
ISIN CNE1000040M1
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
0.54%
Market value
10.17 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
0.44%
Market value
2.77 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
0.39%
Market value
1.61 M
USD
513780
INVESCO Great Wall CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
0.55%
Market value
845.05 K
USD
520700
Wanjia CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
0.53%
Market value
377.74 K
USD
Explore more ETFs
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange HANGZHOU TIGERMED CONSULTING CO LTD. stocks are traded under the ticker HTMDF.
We've gathered analysts' opinions on HANGZHOU TIGERMED CONSULTING CO LTD. future price: according to them, HTMDF price has a max estimate of 7.66 USD and a min estimate of 4.86 USD. Watch HTMDF chart and read a more detailed HANGZHOU TIGERMED CONSULTING CO LTD. stock forecast: see what analysts think of HANGZHOU TIGERMED CONSULTING CO LTD. and suggest that you do with its stocks.
Yes, you can track HANGZHOU TIGERMED CONSULTING CO LTD. financials in yearly and quarterly reports right on TradingView.
HANGZHOU TIGERMED CONSULTING CO LTD. is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
HTMDF earnings for the last quarter are 0.10 USD per share, whereas the estimation was 0.04 USD resulting in a 134.61% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about HANGZHOU TIGERMED CONSULTING CO LTD. earnings.
HANGZHOU TIGERMED CONSULTING CO LTD. revenue for the last quarter amounts to 249.62 M USD, despite the estimated figure of 250.99 M USD. In the next quarter, revenue is expected to reach 243.25 M USD.
HTMDF net income for the last quarter is 89.42 M USD, while the quarter before that showed 29.94 M USD of net income which accounts for 198.70% change. Track more HANGZHOU TIGERMED CONSULTING CO LTD. financial stats to get the full picture.
Yes, HTMDF dividends are paid annually. The last dividend per share was 0.04 USD. As of today, Dividend Yield (TTM)% is 0.64%. Tracking HANGZHOU TIGERMED CONSULTING CO LTD. dividends might help you take more informed decisions.
HANGZHOU TIGERMED CONSULTING CO LTD. dividend yield was 1.05% in 2024, and payout ratio reached 63.89%. The year before the numbers were 1.76% and 24.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 10.19 K employees. See our rating of the largest employees — is HANGZHOU TIGERMED CONSULTING CO LTD. on this list?
Like other stocks, HTMDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANGZHOU TIGERMED CONSULTING CO LTD. stock right from TradingView charts — choose your broker and connect to your account.